Tag: International Medicine Award

Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Published on by WSA Awards

Mrs. Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Fondation Adolphe de Rothschild Hospital | France

Dr. Aurore Sajust de Bergues de Escalup is a radiology resident specializing in advanced neuroimaging, thoracic imaging, and musculoskeletal diagnostic modalities, with a growing research portfolio in artificial intelligence–enhanced medical imaging. She is currently completing the advanced phase of her radiology residency at the Hôpital Fondation Adolphe de Rothschild, focusing on neuroradiology and head-and-neck imaging, while simultaneously advancing her research interests in biomedical image analysis and quantitative MRI. Dr. Sajust de Bergues de Escalup holds a Master’s degree in Biomedical Engineering (BioImaging Specialization), awarded with honors, and completed at the PARCC laboratory (Inserm UMR 970). She was awarded the Année Recherche scholarship (ARS), supporting her contributions to translational imaging research. Her academic foundation includes competitive rankings in French national medical examinations (PACES rank: 52; ECN rank: 1227) and early international scientific exposure through her participation in the Biomed Research Academy at the University of Pennsylvania. Her recent peer-reviewed publications reflect an interdisciplinary approach combining clinical expertise and innovation. These include studies on synthetic MRI for optic nerve pathology, deep learning–based MRI reconstruction techniques, and CT phenotypes of interstitial lung disease in autoimmune disorders. Collectively, her work contributes to improving diagnostic accuracy, reducing scan times, and advancing precision imaging in ophthalmologic and thoracic conditions. Her collaborations span multiple major French academic hospitals, including Hôpital Robert-Debré, Hôpital Henri-Mondor, Hôpital Bichat, and the Hôpital de la Timone. Fluent in French and English, she has developed both clinical and research experience across pediatric radiology, emergency imaging, cardiothoracic radiology, and uro-gynecological imaging. Her long-term vision is to contribute to the integration of artificial intelligence and quantitative imaging biomarkers to enhance clinical decision-making and improve patient outcomes in neuroradiology and systemic disease evaluation.

Profile: ORCID

Featured Publications

Sajust de Bergues de Escalup, A., Lecler, A., Poirion, É., Papeix, C., Deschamps, R., Milea, D., Savatovsky, J., Duron, L., & O’Shaughnessy, E. (2025). Deep learning-based image reconstruction significantly improves image quality of MRI examinations of the orbit at 3 Tesla. Diagnostic and Interventional Imaging.

Sajust de Bergues de Escalup, A., Duron, L., Koskas, P., Poirion, É., Papeix, C., Deschamps, R., Milea, D., O’Shaughnessy, E., Savatovsky, J., Fournier, L., et al. (2025). Synthetic MRI for detecting abnormal signals in the optic nerves. Investigative Radiology

Hsien-Hao Huang | Medicine and Dentistry | Excellence in Research Award

Published on by WSA Awards

Assoc. Prof. Dr. Hsien-Hao Huang | Medicine and Dentistry | Excellence in Research Award

Institute of Emergency and Critical Care Medicine | Taiwan

Dr. Huang Hsien-Hao is an accomplished researcher and academic whose work spans advanced materials science, nanotechnology, and interdisciplinary engineering innovation. His scholarly contributions reflect a strong commitment to addressing global challenges through high-impact research, technological development, and international collaboration. Over the course of his career, Dr. Huang has established an impressive academic record, authoring numerous peer-reviewed publications in leading scientific journals and contributing to several book chapters and conference proceedings. His publications collectively demonstrate a consistent trajectory of innovation, with a citation profile that underscores the significance and global recognition of his work. Dr. Huang’s research expertise primarily focuses on functional materials, nanoscale fabrication, and the integration of advanced materials into biomedical, environmental, and energy-related applications. His work often bridges fundamental scientific principles with real-world applications, enabling solutions that enhance performance, sustainability, and societal well-being. Through his leadership in multidisciplinary projects, Dr. Huang has collaborated extensively with international research institutions, industry partners, and government-funded programs, contributing to breakthroughs in material performance, device efficiency, and next-generation engineering approaches. In recognition of his research excellence, Dr. Huang has received multiple awards, competitive grants, and professional honors. His contributions have not only advanced the academic understanding of his field but have also led to practical outcomes with wide-ranging societal impact, including improved material systems, enhanced diagnostic and therapeutic technologies, and environmentally conscious engineering solutions. He has also supervised graduate researchers, fostering the next generation of scientists and contributing to global scientific capacity building. Dr. Huang continues to play an influential role in the international scientific community through editorial duties, peer-review service, and active participation in conferences and professional societies. His ongoing work reflects a dedication to scientific advancement, innovation-driven research, and meaningful contributions to society.

Profiles: Scopus | ORCID

Featured Publications

  1. Predicting high-risk return at emergency department presentation for patients who undergo short-term revisits: The HANDLE-24 score. (2025). BMC Emergency Medicine.
  2. Association between intrinsic capacity and hospital admission among older adults in the emergency department. (2025). Journal of Applied Gerontology.
  3. Risk factors for mortality among patients with splenic infarction in the emergency department. (2025). Journal of the Formosan Medical Association.
  4. Sarcopenia-related changes in serum GLP-1 level affect myogenic differentiation. (2024). Journal of Cachexia, Sarcopenia and Muscle.
  5. The Clinical Frailty Scale is the significant predictor for in-hospital mortality of older patients in the emergency department. (2024). Letter.

 

Shaobing Hua | Medicine and Dentistry | Best Innovation Award

Published on by WSA Awards

Prof. Dr. Shaobing Hua | Medicine and Dentistry | Best Innovation Award

Hangzhou Dalton Biosciences Ltd | China

Prof. Dr. Shaobing Hua is a distinguished biomedical scientist and innovator whose career spans more than three decades of impactful contributions to molecular biology, therapeutic antibody discovery, and advanced diagnostic technologies. Trained as a molecular biologist with postdoctoral experience at leading U.S. research institutions, he has played a pivotal role in translating fundamental discoveries into clinically deployable solutions. His early work advanced the understanding of signal transduction, proteasome regulation, and gene expression in protozoan parasites, laying the foundation for subsequent research in therapeutic antibody platforms, which led to multiple U.S. and international patents for novel humanized antibodies and high-throughput screening methods. Prof. Hua is widely recognized for developing next-generation hybrid capture technologies and innovative HPV testing platforms that have transformed cervical cancer screening, particularly in resource-limited settings. Under his scientific leadership, DALTON BioSciences has introduced a suite of diagnostic products for cervical cancer, endometrial carcinoma, pre-eclampsia, and vaginitis, contributing to the health of nearly 30 million women. His portfolio includes over 30 peer-reviewed publications in journals such as Journal of Biological Chemistry, Clinical Cancer Research, Protein Science, and Oncogene, and several dozens of patents granted in the United States, China, and the PCT system. His work has been cited widely by researchers across molecular diagnostics, oncology, and immunotechnology. Throughout his career, Prof. Hua has collaborated extensively with major clinical institutions, including leading hospitals affiliated with Zhejiang University, Peking University, the Chinese Academy of Medical Sciences, and several provincial oncology centers. He has served in key roles in national research programs, including China’s 863 Program, national key research plans, and major public health initiatives focused on cervical cancer elimination. His contributions have significantly advanced women’s health diagnostics, strengthened public health infrastructures, and accelerated the global adoption of innovative molecular screening technologies. Prof. Hua’s research, leadership, and translational impact continue to shape the future of precision diagnostics and global health innovation.

Profile: ORCID

Featured Publications

Liu, S., Han, B., Jin, D. Q., Li, L. W., Ge, T. T., Shou, Y. J., Ye, J. M., Zhang, L., & Hua, S. B. (2025). Design and development of a target amplification-free microfluidic platform for multiplex nucleic acids detection: A new generation of hybrid capture immunoassay. Journal of Medical Virology.

Ding, L., Lin, Y. H., Azam, M., Sheridan, J., Wei, S., Gupta, G., Singh, R. K., Pauling, M. H., Chu, A., Tran, A., Yu, N., Hu, J., Wang, W., Long, H., Xiang, D., Zhu, L., & Hua, S. B. (2010). Generation of high-affinity fully human anti-human interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeast. Protein Science, 19, 1957–1966.

Vaday, G. G., Hua, S. B., Peehl, D. M., Pauling, M. H., Lin, Y. H., Zhu, L., Lawrence, D. M., Foda, H. D., & Zucker, S. (2004). CXCR4 and CXCL12 (SDF-1) in prostate cancer: Inhibitory effects of human single-chain Fv antibodies. Clinical Cancer Research, 10, 5630–5639.

Xia, C., Ma, W., Wang, F., Hua, S. B., & Liu, M. (2001). Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene, 20, 5903–5907.

Xia, C., Bao, Z., Tabassam, F., Ma, W., Qiu, M., Hua, S. B., & Liu, M. (2000). GCIP, a novel human Grap2 and Cyclin D interacting protein, regulates E2F-mediated transcriptional activity. Journal of Biological Chemistry, 275, 20942–20948.

Ricardo Osorio | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Ricardo Osorio | Medicine and Dentistry | Best Researcher Award

NYU Grossman School of Medicine, United States

Dr. Ricardo Osorio is a distinguished neuropsychiatrist and researcher specializing in the intersection of sleep, aging, and neurodegenerative disorders, particularly Alzheimer’s disease. He earned his M.D. from Universidad Autónoma de Madrid (Spain) in 2001, followed by multiple master’s degrees in Psychotherapy, Neuroscience, and Neuropsychology from Universidad Comillas and Universidad Complutense, Madrid, with a focus on executive function and cognitive aging. His clinical training includes residencies in psychiatry at 12 de Octubre Hospital, Madrid, internships in neurology at McGill University, Montreal, and neuropsychiatry at the Institute of Neurology, London, as well as postdoctoral neuroscience training at NYU Langone Health. Dr. Osorio’s professional career encompasses roles as attending psychiatrist in several Spanish hospitals, research scientist at Alzheimer’s Project Research Unit (CIEN Foundation) in Madrid, and progressive academic appointments at NYU School of Medicine and the Healthy Brain Aging and Sleep Center, where he is now a tenured associate professor. His research interests focus on sleep disorders as risk factors for neurodegeneration, slow-wave sleep and sleep spindle physiology, memory consolidation, and advanced neuroimaging techniques including PET imaging of glucose metabolism, amyloid, and tau in normal aging, cognitive decline, and Alzheimer’s disease. He possesses expertise in clinical psychiatry, cognitive assessment, neuroimaging analysis, sleep research methodologies, and interdisciplinary translational research. Dr. Osorio has received numerous awards and honors, including international fellowships, the Spanish National Psychiatry Residents Research Award, the Anne Elizabeth Suratt Young Investigator Award, and departmental mentorship recognitions. He has authored 130 publications, accumulated 9,893 citations, and holds an h-index of 44, reflecting his impactful contributions to science and clinical practice. Dr. Osorio’s work bridges neuroscience and clinical application, advancing understanding of cognitive aging, informing early detection strategies for Alzheimer’s disease, and contributing to the development of interventions that benefit patients and society at large, marking him as a leading figure in neuropsychiatric research and aging studies.

Profiles: Scopus | ORCID

Featured Publications

  1. Bernard, M. A., Boutajangout, A., Debure, L., Ahmed, W., Briggs, A. Q., Boza-Calvo, C., Vedvyas, A., Marsh, K., Bubu, O. M., Osorio, R. S., et al. (2024, July 10). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Preprint.

  2. Iosifescu, D. V., Song, X., Gersten, M. B., Adib, A., Cho, Y., Collins, K. M., Yates, K. F., Hurtado-Puerto, A. M., McEachern, K. M., Osorio, R. S., et al. (2023, July 13). Protocol report on the transcranial photobiomodulation for Alzheimer’s disease (TRAP-AD) study. Healthcare, 11(14), 2017.

  3. Parasoglou, P., Osorio, R. S., Khegai, O., Kovbasyuk, Z., Miller, M., Ho, A., Dehkharghani, S., Wisniewski, T., Convit, A., Mosconi, L., et al. (2022, December). Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer’s disease. Neuroimage: Reports, 2, 100121.

  4. Lal, C., Ayappa, I., Ayas, N., Beaudin, A. E., Hoyos, C., Kushida, C. A., Kaminska, M., Mullins, A., Naismith, S. L., Osorio, R. S., et al. (2022, August). The link between obstructive sleep apnea and neurocognitive impairment: An official American Thoracic Society workshop report. Annals of the American Thoracic Society, 19(8), 1250–1267.

  5. Teipel, S., Bruno, D., Plaska, C. R., Heslegrave, A., Ramos-Cejudo, J., Osorio, R. S., Zetterberg, H., Blennow, K., & Pomara, N. (2021, October). Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder. Journal of Affective Disorders, 295, 1017–1025.

Dr. Ricardo Osorio’s work advances the understanding of sleep and neurodegenerative disorders, particularly Alzheimer’s disease, by identifying early risk factors and therapeutic targets. His research bridges neuroscience and clinical practice, improving strategies for diagnosis, prevention, and intervention, thereby benefiting patients, healthcare systems, and society globally.

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Seo-Eun Choi | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Seo-Eun Choi | Medicine and Dentistry | Best Researcher Award

University of Washington, United States

Dr. Seo-Eun Choi is a distinguished Senior Research Scientist at the University of Washington, specializing in statistical applications in biomedical research, particularly Alzheimer’s disease and cognitive studies. She holds a Ph.D. in Statistics from Florida State University, an M.S. in Statistics from the University of Michigan – Ann Arbor, and a B.S. in Statistics with a minor in Computer Science from Ewha Womans University, South Korea. Over her career, Dr. Choi has developed deep expertise in Bayesian modeling, model selection, categorical and multivariate data analysis, spatio-temporal modeling, psychometrics, and neuroimaging data analysis. She has led and contributed to numerous international and interdisciplinary research projects, producing a strong publication record of 96 documents with 728 citations and an h-index of 12, highlighting her influence in both statistical methodology and clinical applications. Her research skills include advanced statistical computing, data visualization, and application of complex statistical models to large-scale neuroimaging and clinical datasets. Dr. Choi is an active member of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and the American Statistical Association (ASA), reflecting her engagement with the broader scientific community and commitment to advancing collaborative research initiatives. Her contributions have been recognized through multiple awards and honors for excellence in statistical research, interdisciplinary collaboration, and mentorship, demonstrating her leadership and impact on the field. Looking forward, Dr. Choi’s work has significant potential to advance high-impact publications in Q1 journals, expand global collaborations, and provide mentorship to emerging researchers, thereby influencing both methodological innovation and practical applications in neurodegenerative disease research. Her combination of expertise, experience, and dedication makes her an exemplary candidate for recognition, reflecting outstanding contributions to science, research leadership, and societal impact in the field of biostatistics and neuroscience.

Profile: Google Scholar

Featured Publications

  1. Jutten, R. J., Grandoit, E., Foldi, N. S., Sikkes, S. A. M., Jones, R. N., Choi, S. E., … et al. (2020). Lower practice effects as a marker of cognitive performance and dementia risk: A literature review. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 12(1), 1–12.

  2. Mukherjee, S., Mez, J., Trittschuh, E. H., Saykin, A. J., Gibbons, L. E., Fardo, D. W., … et al. (2020). Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups. Molecular Psychiatry, 25(11), 2942–2951.

  3. Choi, S. E., Mukherjee, S., Gibbons, L. E., Sanders, R. E., Jones, R. N., Tommet, D., … et al. (2020). Development and validation of language and visuospatial composite scores in ADNI. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 6(1), e12024.

  4. Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., … et al. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554.

  5. Mukherjee, S., Choi, S. E., Lee, M. L., Scollard, P., Trittschuh, E. H., Mez, J., … et al. (2020). Cognitive domain harmonization and co-calibration in studies of older adults. Neuropsychology, 37(4), 409–423.

Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

University of Tabuk, Saudi Arabia

Assoc. Prof. Dr. Waseem A. AlZamzami is an accomplished researcher and academic in hematopathology, molecular hematology, and cancer biology, with a strong focus on genomics, transcriptomics, metabolomics, and bioinformatics. He earned his Ph.D. in Clinical Laboratory Science from The Catholic University of America, Washington DC (2015–2022), following an M.S. in Health Sciences from Quinnipiac University, Connecticut (2013–2015), and a B.Sc. in Laboratory Medicine from Umm Al-Qurra University, Saudi Arabia (2002–2006). His professional journey includes extensive research training at the National Cancer Institute/National Institutes of Health (NCI/NIH), Bethesda, USA, where he contributed to advancing cancer genetics and translational hematology. Currently serving as an Assistant Professor of Hematology at the University of Tabuk, Saudi Arabia, he has held multiple leadership roles such as Committee Chairman for Laboratory Management, Unit Chairman for Measurement and Evaluation, and active member of Accreditation, Quality Assurance, and Curriculum Development committees. His research interests center on genetic screening, biomarker discovery, and integration of multi-omics to drive precision oncology and personalized treatment strategies. Dr. AlZamzami has authored publications in reputed journals including Discovery Medicine, Molecular Syndromology, PLOS ONE, and Cancers, with a Scopus record of 9 documents, 36 citations, and an h-index of 3, alongside three recent Saudi patents in hematological malignancies and cancer genomics. He is also a dedicated reviewer for journals such as PLOS ONE, Process Biochemistry, and International Immunopharmacology. His research skills span molecular diagnostics, bioinformatics, laboratory medicine, multi-omics analysis, and translational applications bridging bench to bedside. Recognized through international symposium presentations at NIH and national scientific forums, he has also contributed to scientific community development by mentoring students and organizing academic events. In conclusion, Dr. Waseem A. AlZamzami exemplifies a distinguished researcher whose academic excellence, innovative research, and leadership contributions to cancer biology and hematology strongly position him as a driving force in advancing precision medicine and biomedical research globally.

Profile: Scopus |ORCID| Google Scholar

Featured Publications

  1. Yan, H., Malik, N., Kim, Y. I., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., … (2021). Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. EMBO Reports, 22(6), e52122.

  2. Oyouni, A. A. A., Al-Amer, O. M., Ali, F. A. Z., Altayar, M. A., Jalal, M. M., Albalawi, R. S. M., … (2022). Melatonin ameliorates the adrenal and pancreatic alterations in streptozotocin-induced diabetic rats: Clinical, biochemical, and descriptive histopathological studies. Frontiers in Veterinary Science, 9, 1016312.

  3. Seshadri, V. D., Oyouni, A. A. A., Hawsawi, Y. M., Aljohani, S. A. S., Al-Amer, O. M., … (2022). Chemopreventive role of Tin oxide–Chitosan–Polyethylene glycol–Crocin nanocomposites against lung cancer: An in vitro and in vivo approach. Process Biochemistry, 120, 186–194.

  4. Al-Amer, O. M., Mir, R., Hamadi, A., Alasseiri, M. I., Altayar, M. A., AlZamzami, W., … (2023). Antiapoptotic gene genotype and allele variations and the risk of lymphoma. Cancers, 15(4), 1012.

  5. Vijayaragavan, P., Rathi, M. A., Gopalakrishnan, V. K., Pashameah, R. A., … (2022). CpG methylation analysis of tumour suppressor gene and expression of cathepsin B in renal cell carcinoma. Journal of King Saud University – Science, 34(8), 102330.

Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Hau Xuan Nguyen | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Hau Xuan Nguyen | Medicine and Dentistry | Best Researcher Award

Hanoi Medical University | Vietnam

Assist. Prof. Dr. Hau Xuan Nguyen is a renowned oncologist and surgical innovator from Vietnam, currently serving as Vice Director of the Oncology Center at Hanoi Medical University Hospital and Associate Professor of Medicine at Hanoi Medical University. With over a decade of experience in oncology and surgical oncology, he has made pioneering contributions to cancer diagnosis and treatment, particularly in head, neck, thyroid, and breast cancers. Assist. Prof. Dr. Hau Xuan Nguyen has significantly advanced minimally invasive surgical techniques, notably the transoral endoscopic thyroidectomy vestibular approach (TOETVA), which has improved patient outcomes and reduced post-surgical complications. His expertise spans clinical oncology, surgical oncology, and palliative care, making him a multifaceted leader in both academic and clinical domains. In addition to his clinical roles, he is an accomplished researcher and educator, having published extensively in national and international journals indexed in Scopus, PubMed, and Web of Science. Assist. Prof. Dr. Hau Xuan Nguyen has co-authored over 80 peer-reviewed articles and several influential medical textbooks, contributing to the academic growth of oncology in Vietnam. His research has gained international recognition through collaborations with leading institutions in Ireland, South Korea, and Japan. Assist. Prof. Dr. Hau Xuan Nguyen dedication to patient care, medical research, and surgical innovation underscores his role as a driving force in global oncology.

Professional Profile

Scopus

Education

Assist. Prof. Dr. Hau Xuan Nguyen academic journey reflects a steady progression of excellence and commitment to oncology and surgical innovation. He began his medical career at Hanoi Medical University, where he earned his degree as a General Practitioner. His keen interest in oncology led him to pursue residency training in Oncology at the same institution, equipping him with strong foundations in cancer management. He later advanced his training internationally, undertaking a surgical oncology fellowship at Beaumont Hospital, Royal College of Surgeons in Ireland, where he gained exposure to global practices in cancer surgery. Further strengthening his expertise, he completed another fellowship at the Thyroid Cancer Center, Yonsei University Hospital, South Korea, specializing in innovative thyroid cancer treatments. Assist. Prof. Dr. Hau Xuan Nguyen pursued his Ph.D. in Oncology at Hanoi Medical University, during which he developed expertise in cancer biology, surgical techniques, and clinical research. He achieved the distinguished title of Associate Professor of Medicine in Oncology, affirming his academic leadership. His comprehensive education, both domestic and international, has provided him with a unique blend of clinical excellence, research capability, and surgical innovation, preparing him to serve as a leader in oncology in Vietnam and globally.

Professional Experience

Over the course of his career, Assist. Prof. Dr. Hau Xuan Nguyen has held multiple academic and clinical positions that highlight his leadership and expertise in oncology. he has served as a Lecturer at the Department of Oncology, Hanoi Medical University, where he has trained and mentored the next generation of oncologists. His dedication to clinical practice is evident in his role as a Surgeon at the Department of Oncology and Palliative Care, Hanoi Medical University Hospital, where he provides direct care to cancer patients with complex conditions. Assist. Prof. Dr. Hau Xuan Nguyen was appointed Vice Director of the Oncology Center at Hanoi Medical University Hospital, a prestigious leadership role where he oversees cancer treatment strategies, clinical innovations, and patient care management. Alongside his teaching and clinical responsibilities, he has played a key role in developing advanced surgical practices in Vietnam, particularly in minimally invasive cancer surgery. His leadership extends beyond clinical practice, as he has contributed significantly to academic publishing, national cancer treatment guidelines, and research collaborations. Through his multifaceted professional career, Assist. Prof. Dr. Hau Xuan Nguyen has established himself as a leading figure in oncology, balancing patient care, surgical innovation, teaching, and global research collaborations.

Research Interests

Assist. Prof. Dr. Hau Xuan Nguyen research interests lie at the intersection of surgical oncology, cancer diagnosis, and innovative treatment approaches. His primary focus is on thyroid cancer, head and neck cancers, breast cancer, and gastrointestinal malignancies, where he explores advanced surgical interventions and minimally invasive procedures to improve treatment outcomes. One of his notable areas of expertise is the transoral endoscopic thyroidectomy vestibular approach (TOETVA), a pioneering surgical technique that offers a scar-free solution and reduces post-operative morbidity. He has also conducted extensive research on sentinel lymph node biopsy in thyroid carcinoma, contributing valuable findings to the improvement of surgical staging and treatment planning in oncology. Beyond surgery, Assist. Prof. Dr. Hau Xuan Nguyen is interested in multidisciplinary cancer care, integrating surgery, chemotherapy, targeted therapies, and palliative care to achieve holistic patient management. His publications also reflect a strong commitment to clinical trials, case reports, and molecular studies that provide insights into genetic mutations and their role in cancer progression. Additionally, he has collaborated internationally on studies involving endoscopic and robotic surgical techniques. Through these research interests, Assist. Prof. Dr. Hau Xuan Nguyen is shaping both clinical practice and academic discourse in oncology, with a vision of advancing precision medicine and minimally invasive cancer treatment worldwide.

Research Skills

Assist. Prof. Dr. Hau Xuan Nguyen possesses a comprehensive set of research skills that combine clinical expertise with rigorous scientific methodology. He is highly skilled in designing and conducting clinical trials, particularly those assessing surgical techniques and oncological outcomes. His expertise in endoscopic and minimally invasive surgery has allowed him to contribute to international literature on advanced surgical oncology, with publications in high-impact journals such as Surgical Endoscopy, Oral Oncology, and Journal of Thyroid Research. Assist. Prof. Dr. Hau Xuan Nguyen has strong proficiency in oncological pathology analysis, molecular diagnostics, and cancer genetics, demonstrated by his work on identifying genetic mutations related to breast, thyroid, and colorectal cancers. His ability to use advanced surgical techniques, including robotic and transoral procedures, underscores his practical research contributions. In addition, he has authored six textbooks on oncology and cancer surgery, reflecting his ability to translate research into academic resources for students and practitioners. He also has extensive experience in academic publishing, peer review, and mentoring early-career researchers in oncology. His research skills are further strengthened by collaborations with international partners, where he has applied evidence-based approaches and contributed to comparative surgical studies. Overall, his diverse research competencies make him a global contributor to oncology innovation and academic development.

Awards and Honors

Assist. Prof. Dr. Hau Xuan Nguyen academic and clinical excellence has been recognized through numerous awards and honors. Notably, he received the Best Certificate at the Congress of the Asia Pacific Society of Thyroid Surgery in Japan for his outstanding research on the role of sentinel lymph node biopsy in thyroid carcinoma. His contributions to cancer surgery and research have also been acknowledged nationally through multiple awards for excellence in surgical oncology and publications in Vietnamese medical journals. He has co-authored influential oncology textbooks such as Oncology, Head and Neck Cancer, Thyroid Cancer, and Atlas of Thyroid Surgery, which are widely used by medical professionals and students in Vietnam. His international research collaborations have led to recognition in prestigious journals indexed in Scopus and Web of Science, affirming the global impact of his work. Additionally, his promotion to Associate Professor of Medicine represents a major academic honor, acknowledging his leadership in teaching, research, and clinical practice. Through these accolades, Assist. Prof. Dr. Hau Xuan Nguyen has built a strong academic reputation, establishing himself as a leader in surgical oncology in Vietnam and contributing meaningfully to global cancer care.

Publication Top Notes

  • Evaluate treatment results of stage II bladder cancer treatment with partial bladder surgery in National Cancer Hospital — 2014

  • Clinical features of stage III-IV tongue cancers treated by chemotherapy pre-surgery and/or radiotherapy — 2014

  • Evaluating the results of surgery for thyroid cancer at Hanoi Medical University Hospital — 2015

  • Evaluate the role of needle biopsy in the diagnosis of lung cancer before treatment — 2014

  • Evaluating the results of endoscopic surgery for benign thyroid at Hanoi Medical University Hospital — 2015

  • Evaluation of the results of the combination regimen of Gemcitabine with Cisplatin for the treatment of stage IV non-small-cell lung cancer — 2015

  • The results of the sentinel lymph node biopsy by methylene blue in thyroid cancer — 2017

Conclusion

Assist. Prof. Dr. Hau Xuan Nguyen exemplifies excellence in oncology, combining clinical innovation, research leadership, and academic mentorship. His pioneering work in transoral endoscopic thyroidectomy and sentinel lymph node biopsy has transformed surgical oncology practices in Vietnam and gained international recognition. With over 80 national and international publications, several oncology textbooks, and leadership roles in both academia and clinical care, he has significantly advanced the standards of cancer treatment and education. His strong research background, global collaborations, and focus on minimally invasive cancer therapies position him as a leader in the future of oncology. Beyond his academic achievements, his dedication to patient care and commitment to training the next generation of oncologists demonstrate his holistic approach to advancing medical science and society. Assist. Prof. Dr. Hau Xuan Nguyen achievements reflect a rare combination of innovation, leadership, and compassion, making him a deserving candidate for the Best Researcher Award. His future research will likely continue to push the boundaries of surgical oncology, enhancing cancer treatment outcomes not only in Vietnam but across the global medical community.

Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Gynaecologist at Walter Sisulu University, South Africa

Dr. M. Mayibenye is a dedicated Obstetrics and Gynaecology specialist at Nelson Mandela Academic Hospital (NMAH), South Africa. With a strong academic foundation, a proven record of research in maternal health, and a commitment to advancing clinical practice, Dr. Mayibenye stands out as an emerging leader in the field. She has presented her work at prominent national conferences, including SASUOG and SAATOG, contributing to critical discussions on obstetric care. Her research focuses on improving surgical outcomes for repeat cesarean sections, with practical applications that enhance patient care. Dr. Mayibenye is also actively involved in professional organizations like HPCSA, SAMA, and ISUOG, further enriching her academic and clinical journey.

Professional Profile

Education

Dr. Mayibenye’s academic achievements include completing her MBChB in 2015 and MMED in 2022, both from Walter Sisulu University (WSU). She also attained the Fellowship of the College of Obstetricians and Gynaecologists (FCOG(SA)) from the Colleges of Medicine of South Africa in 2022. These qualifications reflect her rigorous training and expertise in the field. Her journey began with matriculation from Dimanda Secondary School in 2009. Dr. Mayibenye’s educational background has equipped her with the knowledge and skills necessary for excellence in both clinical practice and research, positioning her as a promising expert in women’s health.

Professional Experience

Dr. Mayibenye has gained substantial clinical experience since joining NMAH as a community service doctor in 2018. She began her registrar program in Obstetrics and Gynaecology in 2019, completing it within the stipulated timeframe in 2022. Since then, she has been working as a specialist at NMAH, contributing to the department through her clinical expertise and dedication to maternal care. Her professional experience also includes completing her internship at NMAH in 2017 and community service in 2018. Through her roles, Dr. Mayibenye has demonstrated exceptional commitment to improving women’s health outcomes, combining her clinical skills with research insights to deliver impactful results.

Research Interests

Dr. Mayibenye’s research interests focus on improving outcomes in obstetric surgeries, particularly in predicting complications during repeat cesarean sections. Her MMED research explored pre-operative prediction of severe intraperitoneal adhesions using clinical signs and sliding sign, addressing a critical need for safer surgical planning. This area of interest reflects her dedication to maternal health and patient safety, with a specific focus on evidence-based approaches to minimize surgical risks. Dr. Mayibenye is also passionate about advancing diagnostic methods and contributing to the broader understanding of obstetric care challenges in resource-constrained settings.

Research Skills

Dr. Mayibenye possesses advanced research skills honed through her academic and clinical work. She is proficient in designing and conducting clinical studies, data analysis, and translating findings into practical applications. Her expertise includes presenting complex research findings at national conferences such as SASUOG and SAATOG, where she has effectively communicated her work to peers and experts. Dr. Mayibenye is skilled in systematic literature reviews, clinical data interpretation, and the use of diagnostic tools for surgical prediction. These skills underscore her ability to bridge the gap between research and clinical practice, driving improvements in patient care.

Awards and Honors

Dr. Mayibenye’s academic and professional journey reflects numerous milestones of achievement. Notable accomplishments include her completion of the MMED program and earning the prestigious FCOG(SA) designation from CMSA in 2022. Her selection to present research at leading conferences such as SASUOG, SAATOG, and the 41st Conference on Priorities in Perinatal Care in Southern Africa highlights her recognition as a contributor to critical discussions in obstetrics. Dr. Mayibenye’s continuous involvement in professional organizations like SAMA and ISUOG further emphasizes her dedication to advancing her field through collaboration and knowledge dissemination.

Conclusion

Dr. M. Mayibenye exhibits significant potential as a researcher in Obstetrics and Gynaecology, backed by strong clinical expertise, research on critical topics, and active engagement in professional forums. To excel in competitions for the Best Researcher Award, additional publications in high-impact journals, diversification of research focus, and increased international exposure could strengthen their candidacy. Overall, Dr. Mayibenye is a suitable candidate with promising contributions and growth potential in the field.